$AIP

JANAC K CHARLES sold $7.0M of AIP (indirect holdings)

JANAC K CHARLES (President and CEO) sold 192,686 indirectly-held shares of Arteris, Inc. (AIP) at an average of $36.32 ($34.77–$43.24, $7.00M total) across 8 trades on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JANAC K CHARLES
Published Jul 6, 2026, 9:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 6, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest concrete fact is the disclosed sale of 192,686 shares (~$6.999M) on July 2 under a Rule 10b5-1 plan; this can influence short-term sentiment but does not provide new company fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure makes this more of a sentiment datapoint than a thesis changer.

03

What to watch

Indirect holdings and multiple small lots across a price range suggest scheduled execution mechanics rather than a new negative catalyst.

Relevance 5/10Novelty 5/10Timing: Filed July 6 after sales executed July 2 (pre-arranged 10b5-1).

Background

The article is a SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP) by its President and CEO, Janac K. Charles.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris CEO Janac K. Charles sold ~$7.0M of AIP shares via a Rule 10b5-1 plan, with weighted-average sale prices $36.32.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived unless accompanied by other news.

Evidence & confidence

The filing is a Form 4 insider transaction with pre-arranged 10b5-1, which typically reduces signaling value versus discretionary selling.

Market effects

Minimal—single-company insider sale without sector-wide regulatory/operational change.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the market may overreact; traders could treat it as routine rather than bearish signal.

Key entities

  • Arteris, Inc.

    Company whose CEO filed the Form 4 disclosing an open-market sale of shares under a 10b5-1 plan.

  • JANAC K CHARLES

    President and CEO; sold 192,686 shares across eight trades on 2026-07-02.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to